ENTITY

Micurx Pharmaceuticals (0276457D US)

1
Analysis
Health CareChina
Micurx Pharmaceuticals Inc. discovers and develops novel antibiotics to combat drug-resistant bacterial infections. The Company offers a pipeline of discovery and development programs for the treatment of Gram-positive bacteria, Gram-negative bacteria and fungal infections. Micurx Pharmaceuticals operates and markets to customers in the United States and China.
more
Refresh
Publication Icon
No publications yet
There aren’t any buy-side reports right now
Back to "All"
x